| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |